Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 2 , ISSUE 3 ( September-December, 2010 ) > List of Articles

CLINICAL PRACTICE

Efficacy of a Selective Estrogen Receptor Modulator: ‘Ormeloxifene’ in Management of Dysfunctional Uterine Bleeding

Tapan Kumar Bhattacharyya, Anusyua Banerji

Citation Information : Bhattacharyya TK, Banerji A. Efficacy of a Selective Estrogen Receptor Modulator: ‘Ormeloxifene’ in Management of Dysfunctional Uterine Bleeding. J South Asian Feder Obs Gynae 2010; 2 (3):207-211.

DOI: 10.5005/jp-journals-10006-1100

Published Online: 01-12-2010

Copyright Statement:  Copyright © 2010; The Author(s).


Abstract

PDF Share
  1. Quality of life—a Swedish survey of 2200 women. In: Smith SK (Ed). Dysfunctional uterine bleeding. London: Royal Society of Medicine Press 1994;36-37.
  2. Do British women undergo too many or too few hysterectomies? Soc Sci Med 1988;27: 987-94.
  3. Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. British Journal of Obstetrics and Gynecology 1995;102:401-06.
  4. Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States. American Journal of Obstetrics and Gynecology 1982;144:841-48.
  5. Randomized controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynecology 1993;100:237-43.
  6. Randomized trial of hysterectomy, endometrial laser ablation and transcervical endometrial resection for dysfunctional uterine bleeding. British Medical Journal 1994;309:979-83.
  7. Endometrial ablation with a thermal balloon for the treatment of menorrhagia. Journal of the American Association of Gynecologic Laparoscopists 1996;3: 383-87.
  8. Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and lipid profile compared to low dose HRT. J Clin Endocrinol Metab 2001;86:755-60.
  9. SERMs: Structure, function and clinical use. Clin Oncol 2000;18:72-86.
  10. Assessment of menstrual blood loss using a pictorial chart. British Journal of Obstetrics and Gynecology 1990;97:734-39.
  11. The effects of danazol, mefenamic acid, norethisterone and a progesteroneimpregnated coil on endometrial prostaglandin concentrations in women with menorrhagia. Prostaglandins 1987;34:99-110.
  12. The effects of mefenamic acid and norethisterone on measured menstrual blood loss. Obstetrics and gynecology 1990;76:85-88.
  13. Treatment of ovulatory and anovulatory dysfunctional uterine bleeding with oral progesterones. Australian and New Zealand Journal of Obstetrics and Gynaecology 1990;30: 353-56.
  14. Randomized comparative study of the levonorgestrel intrauterine system and norethisterone for the treatment of idiopathic menorrhagia. British Journal of Obstetrics and Gynaecology 1998;105:592-98.
  15. Ormeloxifene a selective estrogen receptor modulator, for the treatment of dysfunctional uterine bleeding. J Obstet Gynaecol Ind 2004;54(1):56-59.
  16. Adverse events that are associated with the selective oestrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study. Am J Obstet Gynecol 2002;187:521-27.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.